查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424428

細胞膜穿透勝胜肽的全球市場：按類型、按應用、按最終用戶、按地區

Global Cell Penetrating Peptide Market, By Type, By Application, By End User (Biopharmaceutical Companies, Contract Research Organization /CDMO, Hospitals and Clinics, Others), By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 179 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

細胞膜穿透勝胜肽的全球市場規模預計將從 2023 年的 29.4 億美元增加到 2030 年的 84 億美元，預測期內複合年成長率為 16.2%。

報告範圍 報告詳情
基準年 2022年 2023/2024年市場規模 29.4億美元
實際資料 2017年至2021年 預測期 2023-2030
預測期間 2023/2024 至 2030/2031 年複合年成長率： 16.20% 2030/2031價值預測 84億美元
圖 1. 2023 年細胞膜穿透勝胜肽的全球市場佔有率（%），依地區分類
全球細胞穿透胜肽市場-IMG1

細胞膜穿透勝胜肽（CPP）是短胺基酸序列，可穿過細胞膜並將抗體、核酸和化療藥物等生物活性物質遞送到細胞內。它具有跨越屏障的能力，能夠輸送多種臨床實驗和核准的治療藥物，使其成為重要的分子轉運蛋白。該市場正在進行大量研究，以最佳化細胞膜穿透勝胜肽（CPP）的序列和綴合技術，以提高其藥理特性，如穩定性、溶解度和細胞攝取效率。隨著人們對開發基於 CPP 的治療神經退化疾病和慢性感染疾病等疾病的發行策略的興趣日益濃厚，細胞穿透勝胜肽市場預計將在未來幾年快速成長。

與傳統轉染方法相比，CPP 具有許多優勢，因為它可以在生理條件下非侵入性、高效、快速地將貨物分子遞送至活細胞。由於其易於分子結合和高度生物相容性吸收，CPP 在蛋白質治療、基因轉移和診斷成像等研究和治療應用中具有巨大潛力。然而，其非選擇性雙層破壞和高濃度下可能的細胞毒性仍然是主要挑戰。改進的設計策略旨在開發更安全、更有特異性的CPP。

市場動態：

細胞膜穿透勝胜肽市場的促進因素包括癌症等需要細胞內遞送治療藥物的疾病的增加、研發的進步、製藥公司的投資以及胜肽類藥物的採用增加。然而，與某些 CPP 相關的挑戰，例如穩定性差、不可預測的毒性和免疫反應抑制等，正在阻礙市場成長。繼續研究開發新一代無毒且生物相容的胜肽序列提供了重大機會。

本研究的主要特點

  • 本報告對全球細胞膜穿透勝胜肽市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030年）的市場規模和年複合成長率（CAGR%）。
  • 它還揭示了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球細胞膜穿透勝胜肽市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過分析全球細胞膜穿透勝胜肽市場時所使用的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管場景
  • 服務交付組合
  • PEST分析
  • 波特的分析
  • 併購場景
  • 管道分析

第4章全球細胞膜穿透勝胜肽市場 -冠狀病毒（COVID-19）大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章2018-2030年全球細胞膜穿透勝胜肽市場（依類型）

  • 源自蛋白質的 CPP
  • 合成CPP
  • 嵌合體CPP

第6章 2018-2030 年全球細胞膜穿透勝胜肽市場（依應用）

  • 藥物輸送
  • 基因轉移
  • 診斷
  • 分子影像
  • 其他

第 7 章 全球細胞膜穿透勝胜肽市場，依最終用戶分類，2018-2030 年

  • 生物製藥公司
  • 合約研究組織 (CRO)/CDMO
  • 醫院和診所
  • 其他

第8章2018-2030年全球細胞膜穿透勝胜肽市場（按地區）

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭形勢

  • AnaSpec
  • Peptomyc
  • BioAlps
  • Sarepta Therapeutics, Inc.
  • REVANCE THERAPEUTICS
  • PolyPeptide Group
  • Bachem
  • Pepscan
  • Creative Peptides
  • Cupidpeptides
  • AltaBioscience Ltd

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6553

The global cell penetrating peptide market size is expected to reach US$ 8.40 Bn by 2030, from US$ 2.94 Bn in 2023, exhibiting a CAGR of 16.2% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023/2024: US$ 2.94 Bn
Historical Data for: 2017 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR: 16.20% 2030/2031 Value Projection: US$ 8.40 Bn
Figure 1. Global Cell Penetrating Peptide Market Share (%), By Region, 2023
Global Cell Penetrating Peptide Market - IMG1

Cell penetrating peptides (CPPs) are short sequences of amino acids that are able to cross cell membranes and deliver attached bioactive cargo such as antibodies, nucleic acids, and chemotherapeutics into cells. Their ability to traverse barriers has made them important molecular transporters, enabling the delivery of various investigational and approved therapeutics. The market has witnessed considerable research on optimizing Cell penetrating peptides (CPPs) sequences and conjugation techniques to improve pharmacological properties such as stability, solubility, and cellular uptake efficiency. With growing interest in developing CPP-based delivery strategies for diseases like cancer, neurodegeneration, and chronic infections, the cell penetrating peptide market is anticipated to grow at a rapid pace in the future.

CPPs offer numerous advantages over traditional transfection methods as they provide a non-invasive, efficient, and rapid delivery of cargo molecules into live cells under physiological conditions. Given their easy molecular conjugation and biocompatible uptake, CPPs hold immense potential for research and therapeutic applications including protein therapy, gene delivery, and diagnostic imaging. However, their non-selective bilayer disruption and possible cytotoxicity at higher concentrations remain major challenges. Improved design strategies aim to develop safer and more target-specific CPPs.

Market Dynamics:

The cell penetrating peptide market is driven by rising incidences of diseases such as cancer and others requiring intracellular delivery of therapeutics, increasing research and development, investments by pharmaceutical companies, and growing adoption of peptide-based drugs. However, challenges pertaining to poor stability, unpredictable toxicity, and immune response inhibition associated with some CPPs hamper market growth. Ongoing research to engineer newer generations of non-toxic and biocompatible peptide sequences presents significant opportunities.

Thus, the increasing prevalence of cancer is expected to propel market growth over the forecast period. For instance, according to the data published by the American Cancer Society in 2021, cancer facts and figures in the U.S. reported the estimated number of cancer cases in the U.S. in 2021, which is provided below:

ESTIMATED NEW CANCER CASES IN THE U.S. IN 2021

    • Female Breast Cancer-281,550
    • Lung & bronchus- 235,760
    • Melanoma of the skin- 106,110
    • Urinary bladder- 83,730
    • Prostate-248,530
    • Colon & rectum- 149,500
    • Uterine cervix-281,550
    • Uterine- 149,500
    • corpus Leukemia- 61,090
    • Non Hodgkin lymphoma- 81,560

Key features of the study:

  • This report provides in-depth analysis of the global cell penetrating peptide market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global cell penetrating peptide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include AnaSpec, Peptomyc, BioAlps, Sarepta Therapeutics, Inc., REVANCE THERAPEUTICS, PolyPeptide Group, Bachem, Pepscan Creative Peptides, Cupidpeptides and AltaBioscience Ltd
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global cell penetrating peptide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell penetrating peptide market

Detailed Segmentation:

  • Global Cell Penetrating Peptide Market, By Type
    • Protein Derived CPPs
    • Synthetic CPPs
    • Chimeric CPPs
  • Global Cell Penetrating Peptide Market, By Application
    • Drug Delivery
    • Gene Delivery
    • Diagnostics
    • Molecular Imaging
    • Others
  • Global Cell Penetrating Peptide Market, By End User
    • Biopharmaceutical Companies
    • Contract Research Organization (CROs)/CDMO
    • Hospitals and Clinics
    • Others
  • Global Cell Penetrating Peptide Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Global Cell Penetrating Peptide Market, Key Players
    • AnaSpec
    • Peptomyc
    • BioAlps
    • Sarepta Therapeutics, Inc.
    • REVANCE THERAPEUTICS
    • PolyPeptide Group
    • Bachem
    • Pepscan
    • Creative Peptides
    • Cupidpeptides
    • AltaBioscience Ltd¬

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Cell Penetrating Peptide Market, By Type
    • Global Cell Penetrating Peptide Market, By Application
    • Global Cell Penetrating Peptide Market, By End User
    • Global Cell Penetrating Peptide Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Expanding Applications in Regenerative Medicine
    • Low drug encapsulation efficiency
    • Increasing applications of CPPs in therapeutics development
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Service offering Portfolio
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Pipeline Analysis

4. Global Cell Penetrating Peptide Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Cell Penetrating Peptide Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Protein Derived CPPs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Synthetic CPPs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Chimeric CPPs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Cell Penetrating Peptide Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Drug Delivery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Gene Delivery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Molecular Imaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Cell Penetrating Peptide Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Contract Research Organization (CROs)/CDMO
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Cell Penetrating Peptide Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • AnaSpec
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Peptomyc
  • BioAlps
  • Sarepta Therapeutics, Inc.
  • REVANCE THERAPEUTICS
  • PolyPeptide Group
  • Bachem
  • Pepscan
  • Creative Peptides
  • Cupidpeptides
  • AltaBioscience Ltd
  • Analyst Views

10. Section

  • Research Methodology
  • About us